{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T12:35:29Z","timestamp":1759667729018},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T00:00:00Z","timestamp":1551052800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s00296-019-04261-4","type":"journal-article","created":{"date-parts":[[2019,2,25]],"date-time":"2019-02-25T14:53:03Z","timestamp":1551106383000},"page":"947-955","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The Greek (Hellenic) rheumatology over the years: from ancient to modern times"],"prefix":"10.1007","volume":"39","author":[{"given":"Lazaros I.","family":"Sakkas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Tronzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,25]]},"reference":[{"issue":"8","key":"4261_CR1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5694\/j.1326-5377.2003.tb05254.x","volume":"178","author":"T Tirilomis","year":"2003","unstructured":"Tirilomis T, Malliarou S (2003) Medical history and the European Union: papanicolaou and asklepios. Med J Aust 178(8):380","journal-title":"Med J Aust"},{"key":"4261_CR2","unstructured":"Sanctuary of Asklepios at Epidaurus. UNESCO world Heritage Centre. \n                    http:\/\/whc.unesco.org\n                    \n                  . Culture:World Heritage Centre)"},{"key":"4261_CR3","unstructured":"Hippocrates with an English translation by WHS Jones. W.Heineman, London, Press HU, Cambridge MA. The Loeb classic library. Edited by Page TE, Capps E, Rouse WHD, Post IA, Warmington EH. \n                    http:\/\/ryanfb.github.io\/loebolus-data\/L17.pdf"},{"issue":"Suppl 1","key":"4261_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar1906","volume":"8","author":"G Nuki","year":"2006","unstructured":"Nuki G, Simkin PA (2006) A concise history of gout and hyperuricemia and their treatment. Arthritis Res Ther 8(Suppl 1):S1\u2013S5","journal-title":"Arthritis Res Ther"},{"key":"4261_CR5","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fmicb.2017.01853","volume":"8","author":"LI Sakkas","year":"2017","unstructured":"Sakkas LI, Daoussis D, Liossis SN, Bogdanos DP (2017) The infection besis of ACPA-positive rheumatoid arthritis. Front Microbiol 8:1853. \n                    https:\/\/doi.org\/10.3389\/fmicb.2017.01853","journal-title":"Front Microbiol"},{"key":"4261_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.ajkd.2009.01.275","volume":"54","author":"A Diamantopoulos","year":"2009","unstructured":"Diamantopoulos A, Goudas P, Oreopoulos D (2009) Thirty-six Hippocratic aphorisms of nephrologic interest. Am J kidney Dis 54:143\u2013153","journal-title":"Am J kidney Dis"},{"key":"4261_CR7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bjo.40.6.355","volume":"40","author":"A Feigenbaum","year":"1956","unstructured":"Feigenbaum A (1956) Description of Behcet\u2019s syndrome in the Hippocratic third book of endemic diseases. Br J Ophthalmol 40:355\u2013357","journal-title":"Br J Ophthalmol"},{"key":"4261_CR8","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1136\/bjo.87.9.1175","volume":"87","author":"DH Verity","year":"2003","unstructured":"Verity DH, Wallace GR, Vaughan RW, Stanford MR (2003) Behcet\u2019s disease: from Hippocrates to the third millennium. Br J Ophthalmol 87:1175\u20131183","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4261_CR9","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/0964704X.2010.510180","volume":"20","author":"IG Panourgias","year":"2011","unstructured":"Panourgias IG, Strangalis G, Stavrinou LC, Sakas DE (2011) The Hellenic and Hippocratic origins of the spinal terminology. J Hist Neurosci 20(3):177\u2013187","journal-title":"J Hist Neurosci"},{"key":"4261_CR10","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00586-017-5348-4","volume":"27","author":"H Askitopoulou","year":"2018","unstructured":"Askitopoulou H, Vgontzas AN (2018) The relevance of Hippocratic oath to the ethical and moral values of contemporary medicine. Part I: the Hippocratic oath from antiquity to modern times. Eur Spine J 27:1481\u20131490","journal-title":"Eur Spine J"},{"key":"4261_CR11","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00586-018-5615-z","volume":"27","author":"H Askitopoulou","year":"2018","unstructured":"Askitopoulou H, Vgontzas AN (2018) The relevance of Hippocratic oath to the ethical and moral values of contemporary medicine. Part II: Interpretation of the Hippocratic oath-today\u2019s perspective. Eur Spine J 27:1491\u20131500","journal-title":"Eur Spine J"},{"issue":"7","key":"4261_CR12","first-page":"e3076","volume":"10","author":"SA Clark","year":"2018","unstructured":"Clark SA (2018) The impact of Hippocratic oath in 2018: The conflict of the ideal of the physician, the knowledgeable humanitarian, versus the corporate medical Allegiance to financial models contributes to burnout. Cureus 10(7):e3076","journal-title":"Cureus"},{"key":"4261_CR13","first-page":"11","volume":"2","author":"HN Sallam","year":"2010","unstructured":"Sallam HN (2010) Aristotle, the godfather of evidence-based medicine. FVV ObGyn 2:11\u201319","journal-title":"FVV ObGyn"},{"issue":"17","key":"4261_CR14","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1097\/00007632-199809010-00022","volume":"23","author":"LL Wiltse","year":"1998","unstructured":"Wiltse LL (1998) Herophilus of Alexandria (325\u2013255 B.C). The father of anatomy. Spine 23(17):1904\u20131914","journal-title":"Spine"},{"key":"4261_CR15","first-page":"55","volume":"20","author":"RR Reveron","year":"2014","unstructured":"Reveron RR (2014) Herophilus and Erasistratus, pioneers of anatomical dissection. Vesalius 20:55\u201358","journal-title":"Vesalius"},{"key":"4261_CR16","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/medicines4040092","volume":"4","author":"L Santacroce","year":"2017","unstructured":"Santacroce L, Bottalico L, Charitos IA (2017) Greek medicine practice at ancient Rome: the physician molecularist Asclepiades. Medicines(Basel) 4:92\u201399. \n                    https:\/\/doi.org\/10.3390\/medicines4040092","journal-title":"Medicines(Basel)"},{"key":"4261_CR17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijcard.2013.12.166","volume":"172","author":"A Pasipoularides","year":"2014","unstructured":"Pasipoularides A (2014) Galen, father of systematic medicine. An essay on the evolution of modern medicine and cardiology. Int J Cardiol 172:47","journal-title":"Int J Cardiol"},{"key":"4261_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.urology.2017.03.039","volume":"106","author":"HW Herr","year":"2017","unstructured":"Herr HW (2017) From Galen\u2019s urine to Harvey\u2019s blood. Urology 106:6\u20138","journal-title":"Urology"},{"key":"4261_CR19","unstructured":"Adams F (ed) (1956) The extant work of Aretaeus the Cappadocian. Syndenham Society, London. \n                    https:\/\/archive.org\/details\/b21510271"},{"key":"4261_CR20","doi-asserted-by":"publisher","first-page":"F51","DOI":"10.1136\/fn.73.1.F51","volume":"73","author":"PM Dunn","year":"1995","unstructured":"Dunn PM (1995) Soranus of Ephesus (circa AD 98\u2013138) and perinatal care in Roman times. Arch Dis Child 73:F51\u2013F52","journal-title":"Arch Dis Child"},{"key":"4261_CR21","first-page":"81","volume":"45","author":"M Letts","year":"2016","unstructured":"Letts M (2016) Questioning the patient, questioning Hippocrates: Rufus of Ephesus and the limits of medical authority. Stud Anc Med 45:81\u2013103","journal-title":"Stud Anc Med"},{"key":"4261_CR22","first-page":"89","volume":"9","author":"M Bujalkova","year":"2011","unstructured":"Bujalkova M (2011) Rufus of Ephesus and his contribution to the development of anatomical nomenclature. Acta Med Hist Adriat 9:89\u2013100","journal-title":"Acta Med Hist Adriat"},{"issue":"5","key":"4261_CR23","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s00264-017-3751-4","volume":"42","author":"K Markatos","year":"2018","unstructured":"Markatos K, Korres D, Chytas D et al (2018) Apolloius of Citium (first century BC) and his work on joint dislocations. Int Orthop 42(5):1191\u20131196","journal-title":"Int Orthop"},{"key":"4261_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/shm\/13.2.279","volume":"13","author":"D Bennett","year":"2000","unstructured":"Bennett D (2000) Medical practice and manuscripts in Byzantium. Soc Hist Med 13:279\u2013291","journal-title":"Soc Hist Med"},{"key":"4261_CR25","first-page":"5160","volume":"39","author":"J Scarborough","year":"1997","unstructured":"Scarborough J (1997) The life and times of Alexander of Tralles. Expedition 39:51\u201360","journal-title":"Expedition"},{"key":"4261_CR26","unstructured":"Knight V (2015) The \u201cDe podagra\u201d (\u201cOn gout\u201d): a pre-Gariopontean treatise excerpted from the latin translation of the Greek \u201cTherapeutika\u201d by Alexander of Tralles. Thesis. Manchester University"},{"key":"4261_CR27","unstructured":"Prioreschi P (2001) A history of medicine: Byzantine and Islamic medicine. Horatius Press, Omaha. \n                    http:\/\/books.google.gr\/books?isbn=1888456043"},{"key":"4261_CR28","unstructured":"The Medical Works of Paul Aegineta, the Greek physician. Translated into English with copious commentary by Francis Adams, Esq. J Welsh, Treuttel, Wurtz & Co, London. The Library of the University of Toronto. \n                    http:\/\/ia.802703.us.archive.org\/13\/items\/medicalworksofpa01pauluoft"},{"key":"4261_CR29","first-page":"83","volume":"9","author":"KC Gritzalis","year":"2011","unstructured":"Gritzalis KC, Karamanou M, Androutsos G (2011) gout in the writings of eminent ancient Greek and Byzantine physicians. Acta Med-Hist Adriat 9:83\u201388","journal-title":"Acta Med-Hist Adriat"},{"key":"4261_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.hcl.2010.09.006","volume":"27","author":"P Entezami","year":"2011","unstructured":"Entezami P, Fox DA, Clapham PJ, Chung KC (2011) Historical perspective on the etiology of rheumatoid arthritis. Hand Clin 27:1\u201310. \n                    https:\/\/doi.org\/10.1016\/j.hcl.2010.09.006","journal-title":"Hand Clin"},{"issue":"3","key":"4261_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/art.1780170302","volume":"17","author":"CL Short","year":"1974","unstructured":"Short CL (1974) The antiquity of rheumatoid arthritis. Arthritis Rheum 17(3):193\u2013205","journal-title":"Arthritis Rheum"},{"key":"4261_CR32","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/ard.33.1.77","volume":"33","author":"DE Caughey","year":"1974","unstructured":"Caughey DE (1974) The arthritis of constantine IX. Ann Rheum Dis 33:77\u201380","journal-title":"Ann Rheum Dis"},{"key":"4261_CR33","unstructured":"Michael Psellos. Chronographia 1063. \n                    http:\/\/sourcebooks.fordham.edu\/basis\/psellus-chronographia.asp"},{"key":"4261_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/ard.62.7.691","volume":"62","author":"CC Zouboulis","year":"2003","unstructured":"Zouboulis CC, Kaklamanis P (2003) Early descriptions of Adamantiades-Behcet\u2019s disease. Ann Rheum Dis 62:691\u2013692","journal-title":"Ann Rheum Dis"},{"key":"4261_CR35","first-page":"271","volume":"168","author":"B Adamantiades","year":"1931","unstructured":"Adamantiades B (1931) Sur un cas d\u2019ititis a hypopyon recidivant. Ann Ocul (Paris) 168:271\u2013278","journal-title":"Ann Ocul (Paris)"},{"issue":"5","key":"4261_CR36","first-page":"693","volume":"34","author":"D Vassilopoulos","year":"2016","unstructured":"Vassilopoulos D, Delicha EM, Settas L et al (2016) Safety profile of repeated rituximab cycles in unselected rheumatoid arthritis patients: a long-term, prospective, real-life study. Clin Exp Rheumatol 34(5):693\u2013900","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"4261_CR37","first-page":"579","volume":"35","author":"PP Sfikakis","year":"2017","unstructured":"Sfikakis PP, Bournia VK, Sidiropoulos P et al (2017) Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. Clin Exp Rheumatol 35(4):579\u2013585","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"4261_CR38","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13075-018-1771-0","volume":"20","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Tektonidou M, Drosos AA et al (2018) Prevalence of comorbidities in systemic sclerosis versus rheumatoid arthritis: a comparative multicenter, matched-cohort study. Arthritis Res Ther 20(1):267","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"4261_CR39","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R et al (2002) European study group on classification criteria for Sj\u00f6gren\u2019s syndrome. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group. Ann Rheum Dis 61(6):554\u2013558","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4261_CR40","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s12016-007-8042-1","volume":"32","author":"HM Moutsopoulos","year":"2007","unstructured":"Moutsopoulos HM (2007) Sj\u00f6gren\u2019s syndrome or autoimmune epithelitis? Clin Rev Allergy Immunol 32(3):199\u2013200","journal-title":"Clin Rev Allergy Immunol"},{"issue":"12","key":"4261_CR41","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1093\/rheumatology\/kev200","volume":"54","author":"M Ramos-Casals","year":"2015","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Seror R et al (2015) EULAR Sj\u00f6gren Syndrome Task Force. Characterization of systemic disease in primary Sj\u00f6gren\u2019s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology 54(12):2230\u20132238. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kev200\n                    \n                  . (Erratum in: Rheumatology (Oxford). 2017 Jul 1;56(7):1245)","journal-title":"Rheumatology"},{"issue":"2","key":"4261_CR42","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A et al (2016) EULAR Sj\u00f6gren\u2019s Task Force. Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75(2):382\u2013389. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"4261_CR43","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1136\/annrheumdis-2013-204792","volume":"73","author":"AG Semb","year":"2014","unstructured":"Semb AG, Rollefstad S, van Riel P et al (2014) Cardiovascular disease assessment in rheumatoid arthritis: a guide to translating knowledge of cardiovascular risk into clinical practice. Ann Rheum Dis 73(7):1284\u20131288. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2013-204792","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4261_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","volume":"77","author":"CS Crowson","year":"2018","unstructured":"Crowson CS, Rollefstad S, Ikdahl E, A Trans-Atlantic Cardiovascular Consortium for Rheumatoid Arthritis (ATACC-RA) et al (2018) Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis. Ann Rheum Dis 77(1):48\u201354. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2017-211735","journal-title":"Ann Rheum Dis"},{"issue":"8822","key":"4261_CR45","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","volume":"340","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Austin HA, Vaughn EM et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340(8822):741\u2013745","journal-title":"Lancet"},{"issue":"12","key":"4261_CR46","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias GK, Ioannidis JP, Aringer M et al (2010) EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 69(12):2074\u20132082. \n                    https:\/\/doi.org\/10.1136\/ard.2010.130476","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"4261_CR47","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z et al (2012) European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association. Joint European League against Rheumatism and European Renal Association-European Dialysis and Association T (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71(11):1771\u20131782. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2012-201940","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4261_CR48","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","volume":"76","author":"L Andreoli","year":"2017","unstructured":"Andreoli L, Bertsias GK, Agmon-Levin N et al (2017) EULAR recommendations for women\u2019s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476\u2013485. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-209770","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"4261_CR49","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1172\/JCI78087","volume":"125","author":"VR Moulton","year":"2015","unstructured":"Moulton VR, Tsokos GC (2015) T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest 125(6):2220\u20132227. \n                    https:\/\/doi.org\/10.1172\/JCI78087","journal-title":"J Clin Invest"},{"issue":"12","key":"4261_CR50","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2018","unstructured":"Tsokos GC, Lo MS, Costa Reis P, Sullivan KE (2018) New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 12(12):716\u2013730. \n                    https:\/\/doi.org\/10.1038\/nrrheum.2016.186","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"4261_CR51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.7326\/0003-4819-140-5-200403020-00025","volume":"2","author":"PP Sfikakis","year":"2004","unstructured":"Sfikakis PP, Kaklamanis PH, Elezoglou A et al (2004 Mar) Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Beh\u00e7et disease. Ann Intern Med 2(5):404\u2013406 140(","journal-title":"Ann Intern Med"},{"issue":"6","key":"4261_CR52","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","volume":"77","author":"G Hatemi","year":"2018","unstructured":"Hatemi G, Christensen R, Bang D et al (2018) 2018 update of the EULAR recommendations for the management of Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 77(6):808\u2013818. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2018-213225","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"4261_CR53","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"International Team for the Revision of the International Criteria for","year":"2014","unstructured":"International Team for the Revision of the International Criteria for Beh\u00e7et\u2019s Disease (ITR-ICBD) (2014) The International Criteria for Beh\u00e7et\u2019s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28(3):338\u2013347. \n                    https:\/\/doi.org\/10.1111\/jdv.12107","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"4261_CR54","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/ard.2006.062091","volume":"66","author":"W Zhang","year":"2007","unstructured":"Zhang W, Doherty M, Leeb BF et al (2007) EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing committee for international clinical studies including therapeutics (ESCISIT). Ann Rheum Dis 66(3):377\u2013388","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4261_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/ard.2007.084772","volume":"68","author":"W Zhang","year":"2009","unstructured":"Zhang W, Doherty M, Leeb BF et al (2009) EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis: report of a task force of ESCISIT. Ann Rheum Dis 68(1):8\u201317. \n                    https:\/\/doi.org\/10.1136\/ard.2007.084772","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"4261_CR56","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/ncprheum0346","volume":"2","author":"LI Sakkas","year":"2006","unstructured":"Sakkas LI, Chikanza IC, Platsoucas CD (2006) Mechanisms of disease: the role of immune cells in the pathogenesis of systemic sclerosis. Nat Clin Pract Rheumatol 2(12):679\u2013685","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"2","key":"4261_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/art.39437","volume":"68","author":"A Mavropoulos","year":"2016","unstructured":"Mavropoulos A, Simopoulou T, Varna A et al (2016) Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis. Arthritis Rheumatol 68(2):494\u2013504. \n                    https:\/\/doi.org\/10.1002\/art.39437","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"4261_CR58","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/rheumatology\/kep093","volume":"49","author":"D Daoussis","year":"2010","unstructured":"Daoussis D, Liossis SN, Tsamandas AC et al (2010) Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study. Rheumatology 49(2):271\u2013280. \n                    https:\/\/doi.org\/10.1093\/rheumatology\/kep093","journal-title":"Rheumatology"},{"issue":"1","key":"4261_CR59","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13075-016-1017-y","volume":"18","author":"D Daoussis","year":"2016","unstructured":"Daoussis D, Tsamandas A, Antonopoulos I et al (2016) B cell depletion therapy upregulates Dkk-1 skin expression in patients with systemic sclerosis: association with enhanced resolution of skin fibrosis. Arthritis Res Ther 18(1):118. \n                    https:\/\/doi.org\/10.1186\/s13075-016-1017-y","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"4261_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3899\/jrheum.100514","volume":"38","author":"TE Markatseli","year":"2011","unstructured":"Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA (2011) Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study. J Rheumatol 38(1):44\u201352. \n                    https:\/\/doi.org\/10.3899\/jrheum.100514\n                    \n                  . (Epub 2010 Oct 15)","journal-title":"J Rheumatol"},{"key":"4261_CR61","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key372","author":"J Braun","year":"2018","unstructured":"Braun J, Baraliakos X (2018) Active and chronic sacroiliitis, spondylitis and enthesitis, how specific are imaging findings for axial spondyloarthritis? Rheumatology (Oxford). \n                    https:\/\/doi.org\/10.1093\/rheumatology\/key372\n                    \n                  . (Epub ahead of print)","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"4261_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","volume":"77","author":"JS Smolen","year":"2018","unstructured":"Smolen JS, Sch\u00f6ls M, Braun J et al (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Ann Rheum Dis 77(1):3\u201317. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2017-211734\n                    \n                  \n                           (Erratum in: Ann Rheum Dis. 2018 Mar;77(3):472)","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"4261_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.rdc.2016.09.012","volume":"43","author":"C Koutsianas","year":"2017","unstructured":"Koutsianas C, Thomas K, Vassilopoulos D (2017) Hepatitis B reactivation in rheumatic diseases: screening and prevention. Rheum Dis Clin N Am 43(1):133\u2013149. \n                    https:\/\/doi.org\/10.1016\/j.rdc.2016.09.012","journal-title":"Rheum Dis Clin N Am"},{"issue":"5","key":"4261_CR64","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.berh.2016.10.009","volume":"30","author":"K Thomas","year":"2016","unstructured":"Thomas K, Vassilopoulos D (2016) Immunization in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30(5):946\u2013963. \n                    https:\/\/doi.org\/10.1016\/j.berh.2016.10.009","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"4261_CR65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/BOR.0000000000000503","volume":"30","author":"LI Sakkas","year":"2018","unstructured":"Sakkas LI, Bogdanos DP (2018) Multiple hit infection and autoimmunity: the dysbiotic microbiota-ACPA connection in rheumatoid arthritis. Curr Opin Rheumatol 30(4):403\u2013409. \n                    https:\/\/doi.org\/10.1097\/BOR.0000000000000503","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"4261_CR66","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.20433","volume":"50","author":"MG Tektonidou","year":"2004","unstructured":"Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM (2004) Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome. Arthritis Rheum 50(8):2569\u20132579","journal-title":"Arthritis Rheum"},{"issue":"5","key":"4261_CR67","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","volume":"14","author":"MM Abreu","year":"2015","unstructured":"Abreu MM, Danowski A, Wahl DG et al (2015) The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International Congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun Rev 14(5):401\u2013414. \n                    https:\/\/doi.org\/10.1016\/j.autrev.2015.01.002","journal-title":"Autoimmun Rev"},{"issue":"5","key":"4261_CR68","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3899\/jrheum.090931","volume":"37","author":"T Dimitroulas","year":"2010","unstructured":"Dimitroulas T, Giannakoulas G, Papadopoulou K et al (2010) Early detection of cardiac involvement in systemic sclerosis assessed by tissue-Doppler echocardiography: relationship with neurohormonal activation and endothelial dysfunction. J Rheumatol 37(5):993\u2013999. \n                    https:\/\/doi.org\/10.3899\/jrheum.090931","journal-title":"J Rheumatol"},{"key":"4261_CR69","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijcard.2016.04.158","volume":"217","author":"SI Mavrogeni","year":"2016","unstructured":"Mavrogeni SI, Kitas GD, Dimitroulas T et al (2016) Cardiovascular magnetic resonance in rheumatology: current status and recommendations for use. Int J Cardiol 217:135\u2013148. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2016.04.158","journal-title":"Int J Cardiol"},{"key":"4261_CR70","doi-asserted-by":"publisher","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76(6):960\u2013977. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2016-210715","DOI":"10.1136\/annrheumdis-2016-210715"},{"issue":"4","key":"4261_CR71","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/annrheumdis-2017-212256","volume":"77","author":"H Radner","year":"2018","unstructured":"Radner H, Chatzidionysiou K, Nikiphorou E et al (2018) 2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis. Ann Rheum Dis 77(4):476\u2013479. \n                    https:\/\/doi.org\/10.1136\/annrheumdis-2017-212256\n                    \n                  .","journal-title":"Ann Rheum Dis"},{"key":"4261_CR72","doi-asserted-by":"publisher","first-page":"E513","DOI":"10.1097\/BRS.0b013e3181a9897e","volume":"34","author":"LI Sakkas","year":"1976","unstructured":"Sakkas LI, Davas EM, Kapsalaki E et al (1976) Hematogenous spondylitis in central Greece. Spine (Phila PA) 34:E513\u2013E518","journal-title":"Spine (Phila PA)"},{"issue":"7","key":"4261_CR73","first-page":"1589","volume":"30","author":"A Andrianakos","year":"2003","unstructured":"Andrianakos A, Trontzas P, Christoyannis F et al (2003) Prevalence of rheumatic diseases in Greece: a cross-sectional population based epidemiological study. The ESORDIG Study. J Rheumatol 30(7):1589\u20131601","journal-title":"J Rheumatol"},{"issue":"12","key":"4261_CR74","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/rheumatology\/kel140","volume":"45","author":"A Andrianakos","year":"2006","unstructured":"Andrianakos A, Trontzas P, Christoyannis F et al (2006) Prevalence and management of rheumatoid arthritis in the general population of Greece\u2014the ESORDIG study. Rheumatology 45(12):1549\u20131554","journal-title":"Rheumatology"},{"key":"4261_CR75","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1471-2474-11-98","volume":"11","author":"I Anagnostopoulos","year":"2010","unstructured":"Anagnostopoulos I, Zinzaras E, Alexiou I et al (2010) The prevalence of rheumatic diseases in central Greece: a population survey. BMC Musculoskelet Disord 11:98","journal-title":"BMC Musculoskelet Disord"},{"issue":"6","key":"4261_CR76","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s10067-005-1106-9","volume":"24","author":"P Trontzas","year":"2005","unstructured":"Trontzas P, Andrianakos A, Miyakis S et al (2005) Seronegative spondyloarthropathies in Greece: a population-based study of prevalence, clinical pattern, and management. The ESORDIG study. Clin Rheumatol 24(6):583\u2013589","journal-title":"Clin Rheumatol"},{"issue":"12","key":"4261_CR77","first-page":"2507","volume":"33","author":"AA Andrianakos","year":"2006","unstructured":"Andrianakos AA, Kontelis LK, Karamitsos DG et al (2006) Prevalence of symptomatic knee, hand, and hip osteoarthritis in Greece. The ESORDIG study. J Rheumatol 33(12):2507\u20132513","journal-title":"J Rheumatol"},{"issue":"7","key":"4261_CR78","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/rheumatology\/keh650","volume":"44","author":"AA Andrianakos","year":"2005","unstructured":"Andrianakos AA, Miyakis S, Trontzas P et al (2005) The burden of the rheumatic diseases in the general adult population of Greece: the ESORDIG study. Rheumatology 44(7):932\u2013938","journal-title":"Rheumatology"},{"issue":"4","key":"4261_CR79","first-page":"579","volume":"35","author":"PP Sfikakis","year":"2017","unstructured":"Sfikakis PP, Bournia V-K, Sidiropoulos P et al (2017) Biologic treatment for rheumatic disease: real-world big data analysis from the Greek country-wide prescription database. Clin Exp Rheumatol 35(4):579\u2013585","journal-title":"Clin Exp Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04261-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04261-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T00:08:14Z","timestamp":1582589294000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04261-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,25]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["4261"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04261-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,25]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Author LIS has received speaker honoraria from Actelion, Janssen, Novartis, Abbvie, Roche Sanofi- Aventis, Pfizer. Author Panagiotis Trontzas has received speaker honoraria from Menarini, UCB, Pfizer, Roche, Bristol-Meyers Squibb, Novartis, Pfizer, MSD.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}